Related Experiment Video
Updated: Jun 3, 2026

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
Published on: July 29, 2014
Differential recognition of viral RNA by RIG-I
Alina Baum1, Adolfo García-Sastre
1Department of Microbiology, Mount Sinai School of Medicine, New York, NY, USA.
Abstract:
Retinoic acid inducible gene I (RIG-I) is a pattern recognition receptor (PRR) responsible for detection of nucleic acids from pathogens in the cytoplasm of infected cells and induction of type I interferon (IFN). RIG-I -specific pathogen associated molecular patterns (PAMPs) are characterized by RNA molecules with a 5'-triphosphate (5'-ppp) group and partial double-stranded composition. Although many RNA molecules capable of activating RIG-I have been described, the exact nature of viral RNAs which are responsible for triggering RIG-I activity during the course of an infection has not been extensively explored and the specificity of RIG-I for various viral RNA molecules remains largely unknown. By examining endogenous RIG-I/RNA complexes in influenza virus and Sendai virus infected cells we were able to identify viral RNA molecules which specifically associated with RIG-I during infection. We showed that in Sendai virus infected cells, RIG-I specifically and preferentially associated with the copy-back defective interfering (DI) particle RNA and not with the full-length Sendai virus genome or Sendai virus encoded mRNAs. In influenza virus infected cells RIG-I also preferentially associated with DI RNAs as well as with the shorter genomic segments.
Insights
Retinoic acid inducible gene I (RIG-I) preferentially binds defective interfering (DI) RNAs and shorter genomic segments from influenza and Sendai viruses during infection. This specificity clarifies RIG-I
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Retinoic acid inducible gene I (RIG-I) is a crucial pattern recognition receptor (PRR) that detects cytoplasmic pathogen-associated molecular patterns (PAMPs), primarily viral RNA with a 5'-triphosphate (5'-ppp) group.
- RIG-I activation initiates innate immune responses, including type I interferon (IFN) production, essential for controlling viral infections.
- The precise viral RNA structures that trigger RIG-I during natural infections and RIG-I's specificity for diverse viral RNA molecules remain incompletely understood.
Purpose of the Study:
- To identify specific viral RNA molecules that associate with RIG-I during influenza and Sendai virus infections.
- To elucidate the specificity of RIG-I binding to different viral RNA species within infected cells.
Main Methods:
- Analysis of endogenous RIG-I/RNA complexes isolated from cells infected with influenza virus and Sendai virus.
- Characterization of viral RNA species bound to RIG-I using molecular techniques.
Main Results:
- In Sendai virus-infected cells, RIG-I selectively bound to copy-back defective interfering (DI) particle RNA, excluding the full-length viral genome and mRNAs.
- In influenza virus-infected cells, RIG-I preferentially associated with DI RNAs and shorter genomic segments.
- These findings highlight RIG-I's specific recognition of non-canonical viral RNA structures during infection.
Conclusions:
- RIG-I exhibits distinct specificity for viral RNA molecules during infection, favoring defective interfering RNAs and shorter genomic segments.
- This preferential binding suggests a mechanism for RIG-I to distinguish between viral replication intermediates or defective genomes and host or standard viral RNAs.
- Understanding RIG-I specificity is critical for developing antiviral strategies targeting innate immune sensing pathways.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Leaky Scanning
Viruses with RNA Genomes
The Antiviral System of Bacteria and Archaea: CRISPR

